✨
AI Summary
- Mammoth Biosciences explores ultracompact CRISPR systems for curative therapies.
- Delivery challenges for in vivo gene editing are a key focus.
- Proprietary CRISPR technology aims to overcome these delivery bottlenecks.
Guests on This Episode
LH
Lucas Harrington
1 podcast appearance